Furthermore, levels of OVA‐specific IgE and Th2‐associated cytokines (IL‐4, IL‐5, IL‐13) in BALF were significantly reduced in the sLNP‐OVA/Cel treated group compared to other asthma treatment groups (Figure S5D,E, Supporting Information). This evidence concerns the gene IL5 and asthma.